It really can't be argued. Three of the leading researchers in Alzheimer's and CTE agree to be part of AMBS Scientific Advisory Board. Not to mention one of them is currently with the only company that has even a mediocre, at best, Alzheimer's diagnostic. Speaks volumes for the current state of Lympro and the potential. It certainly will add further credibility for the product and company and should garner more BP attention.